Clinical Trials List
2022-10-31 - 2026-09-30
Phase III
Recruiting2
ICD-10E75.21
Fabry (-Anderson) disease
ICD-10E75.22
Gaucher disease
ICD-10E75.240
Niemann-Pick disease type A
ICD-10E75.241
Niemann-Pick disease type B
ICD-10E75.242
Niemann-Pick disease type C
ICD-10E75.243
Niemann-Pick disease type D
ICD-10E75.248
Other Niemann-Pick disease
ICD-10E75.249
Niemann-Pick disease, unspecified
ICD-10E75.3
Sphingolipidosis, unspecified
ICD-10E77.0
Defects in post-translational modification of lysosomal enzymes
ICD-10E77.1
Defects in glycoprotein degradation
ICD-10E77.8
Other disorders of glycoprotein metabolism
ICD-10E77.9
Disorder of glycoprotein metabolism, unspecified
ICD-9272.7
Lipidoses
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 藍振嘉 Division of Psychiatry
- 周政達 Division of Neurology
- 張鈺斌 Division of Radiology
- WEI-WEN LIN Division of Cardiovascular Diseases
- 周建志 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
90 participants
